Table 5.
Comparison of serum CK, LDH, CRP, and FCal over time between medication groups
| Laboratory marker | Medication/comparison | GMR (95% CI) | p value |
|---|---|---|---|
| CK | Infliximab versus vedolizumab | 0.91 (0.53; 1.55) | 0.7221 |
| LDH | Infliximab versus vedolizumab | 0.93 (o.84; 1.02) | 0.1216 |
| CRP | Infliximab versus vedolizumab | 0.68 (0.28; 1.67) | 0.4006 |
| FCal | Infliximab versus vedolizumab | 7.28 (2.22; 23.86) | 0.001 |
CK, creatine kinase; LDH, lactate dehydrogenase; CRP, C-reactive protein; FCal, fecal calprotectin; CI, confidence interval; GMR, geometric mean ratio.